Skip to main content
Ninad Zaman, DO, Cardiology, Columbia, SC

NinadMohammedZamanDO

Cardiology Columbia, SC

Cardiology Fellow, PGY-6

Dr. Zaman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Zaman's full profile

Already have an account?

  • Office

    8 Richland Medical Park Drive
    Suite 425
    Columbia, SC 29203
    Phone+1 803-545-5447

Education & Training

  • Prisma Health/University of South Carolina SOM Columbia (Columbia)
    Prisma Health/University of South Carolina SOM Columbia (Columbia)Fellowship, Cardiovascular Disease, 2021 - 2024
  • Penn State Milton S Hershey Medical Center
    Penn State Milton S Hershey Medical CenterResidency, Internal Medicine, 2018 - 2021
  • Campbell University School of Osteopathic Medicine
    Campbell University School of Osteopathic MedicineClass of 2018, DO, Summa Cum Laude
  • George Mason University
    George Mason UniversityBS, Biology , Magna Cum Laude, 2009 - 2013

Certifications & Licensure

  • NY State Medical License
    NY State License 2023 - 2025
  • SC State Medical License
    SC State License 2021 - 2024
  • VA State Medical License
    VA State License 2021 - 2024
  • NC State Medical License
    NC State License 2022 - 2023
  • PA State Medical License
    PA State License 2018 - 2021
  • American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

Abstracts/Posters

  • A Comparison of Rate Control Agents in Patients With Atrial Fibrillation: Follow-up Investigation of Affirm Study
    Ninad Zaman, Gerald Naccarelli and Andrew Foy, Circulation, 11/12/2020
  • Colchicine for Secondary Prevention of Adverse Outcomes From Cardiovascular Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Ninad Zaman, Simran Grewal, Louis Borgatta, Matthew Nudy, Brandon Peterson, Circulation, 11/12/2020
  • Glucagon-like Peptide-1 Receptor Agonists Reduce Adverse Cardiovascular Disease (CVD) Events in Patients With Type 2 Diabetes: An Assessment of Heterogeneity Among CVD...
    Simran Grewal, Ninad Zaman, Louis Borgatta, Matthew Nudy, Brandon Peterson, Circulation, 11/12/2020
  • Join now to see all

Professional Memberships

Other Languages

  • Bengali